387 related articles for article (PubMed ID: 18262761)
41. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
Langendijk JA; Doornaert P; Rietveld DH; Verdonck-de Leeuw IM; Leemans CR; Slotman BJ
Radiother Oncol; 2009 Feb; 90(2):189-95. PubMed ID: 19167120
[TBL] [Abstract][Full Text] [Related]
42. [Hyperbaric oxygenation in osteoradionecrosis of the mandible].
Thiel HJ
Strahlenther Onkol; 1994 Oct; 170(10):614-5. PubMed ID: 7974176
[No Abstract] [Full Text] [Related]
43. Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up.
Nordgren M; Jannert M; Boysen M; Ahlner-Elmqvist M; Silander E; Bjordal K; Hammerlid E
Head Neck; 2006 Apr; 28(4):339-49. PubMed ID: 16287136
[TBL] [Abstract][Full Text] [Related]
44. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.
Lin SC; Jen YM; Chang YC; Lin CC
J Pain Symptom Manage; 2008 Aug; 36(2):141-8. PubMed ID: 18395402
[TBL] [Abstract][Full Text] [Related]
45. Submandibular gland transfer for prevention of xerostomia after radiation therapy: swallowing outcomes.
Rieger J; Seikaly H; Jha N; Harris J; Williams D; Liu R; McGaw T; Wolfaardt J
Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):140-5. PubMed ID: 15723946
[TBL] [Abstract][Full Text] [Related]
46. Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.
Monnier Y; Broome M; Betz M; Bouferrache K; Ozsahin M; Jaques B
Otolaryngol Head Neck Surg; 2011 May; 144(5):726-32. PubMed ID: 21493361
[TBL] [Abstract][Full Text] [Related]
47. Improved quality of life with hyperbaric oxygen therapy in patients with persistent pelvic radiation-induced toxicity.
Safra T; Gutman G; Fishlev G; Soyfer V; Gall N; Lessing JB; Almog R; Matcievsky D; Grisaru D
Clin Oncol (R Coll Radiol); 2008 May; 20(4):284-7. PubMed ID: 18222656
[TBL] [Abstract][Full Text] [Related]
48. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
[TBL] [Abstract][Full Text] [Related]
49. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation.
Mowry SE; Ho A; Lotempio MM; Sadeghi A; Blackwell KE; Wang MB
Laryngoscope; 2006 Sep; 116(9):1589-93. PubMed ID: 16954985
[TBL] [Abstract][Full Text] [Related]
50. Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer.
Meijer TWH; Scandurra D; Langendijk JA
Br J Radiol; 2020 Mar; 93(1107):20190955. PubMed ID: 31971818
[TBL] [Abstract][Full Text] [Related]
51. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.
McMillan AS; Pow EH; Kwong DL; Wong MC; Sham JS; Leung LH; Leung WK
Head Neck; 2006 Aug; 28(8):712-22. PubMed ID: 16475203
[TBL] [Abstract][Full Text] [Related]
52. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Duncan GG; Epstein JB; Tu D; El Sayed S; Bezjak A; Ottaway J; Pater J;
Head Neck; 2005 May; 27(5):421-8. PubMed ID: 15782422
[TBL] [Abstract][Full Text] [Related]
53. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia.
Ringash J; Warde P; Lockwood G; O'Sullivan B; Waldron J; Cummings B
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1403-7. PubMed ID: 15817343
[TBL] [Abstract][Full Text] [Related]
54. Oral and dental management related to radiation therapy for head and neck cancer.
Hancock PJ; Epstein JB; Sadler GR
J Can Dent Assoc; 2003 Oct; 69(9):585-90. PubMed ID: 14653934
[TBL] [Abstract][Full Text] [Related]
55. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
Al-Qahtani K; Hier MP; Sultanum K; Black MJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):753-6. PubMed ID: 16731395
[TBL] [Abstract][Full Text] [Related]
56. Speech and swallowing impairment after treatment for oral and oropharyngeal cancer.
Suarez-Cunqueiro MM; Schramm A; Schoen R; Seoane-Lestón J; Otero-Cepeda XL; Bormann KH; Kokemueller H; Metzger M; Diz-Dios P; Gellrich NC
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1299-304. PubMed ID: 19075126
[TBL] [Abstract][Full Text] [Related]
57. [Side effects of radiotherapy in oral cavity: diagnosis, prevention and treatment guidelines].
Badzek S; Tomas I; Krajina I; Pućo K; Kelović VL; Krajina Z; Plestina S
Lijec Vjesn; 2009; 131(11-12):324-7. PubMed ID: 20143603
[TBL] [Abstract][Full Text] [Related]
58. Quality of life in head and neck cancer survivors: a cross-sectional survey.
Chaukar DA; Walvekar RR; Das AK; Deshpande MS; Pai PS; Chaturvedi P; Kakade A; D'Cruz AK
Am J Otolaryngol; 2009; 30(3):176-80. PubMed ID: 19410123
[TBL] [Abstract][Full Text] [Related]
59. Quality of life in patients with oral and oropharyngeal cancer.
Infante-Cossio P; Torres-Carranza E; Cayuela A; Gutierrez-Perez JL; Gili-Miner M
Int J Oral Maxillofac Surg; 2009 Mar; 38(3):250-5. PubMed ID: 19135864
[TBL] [Abstract][Full Text] [Related]
60. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia.
Seikaly H; Jha N; Harris JR; Barnaby P; Liu R; Williams D; McGaw T; Rieger J; Wolfaardt J; Hanson J
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):956-61. PubMed ID: 15313866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
